Enovis CORP

ENOV

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 127,270Value: $3.4M

# Signal Note: Deerfield Management Initiates ENOV Position Deerfield's $3.4M entry into Enovis (orthopedic/specialty surgical devices) signals conviction in the company's surgical recovery trajectory post-COVID, likely driven by normalized OR utilization and upcoming product launches in spine/extremities. The timing aligns with potential procedure volume normalization and margin expansion as supply chain constraints ease. Watch for upcoming earnings revisions and procedural volume trends as near-term catalysts.

More ENOV Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

RDNT1 fund VTR1 fund PHVS1 fund PMVP1 fund ALHC1 fund ATRC1 fund BCRX1 fund NBIX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: